Lung Cancer · 2020 · 25 citations · 32 references
MedicineMolecular MedicineOncologyMolecular OncologyNeoplasiaTumor ProgressionCancer BiomarkersCancer Molecular DiagnosticsCirculating Tumor Dna AnalysisLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsCirculating Tumor BiomarkersCirculating Tumor Dna DetectionCirculating Tumor Dna DynamicsCirculating Tumor Dna SequencingCirculating Tumor Dna TestingDurable Clinical ResponseTumor Mutation Detection
32
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al. · New England Journal of Medicine · 2009 · 8.2K citations · Full text
Medicine, Oncology, Pharmacology +13
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations
Medicine, Oncology, Pharmacology +13
Rafael Rosell, Enric Carcereny, Radj Gervais et al. · The Lancet Oncology · 2012 · 5.5K citations · Full text
Medicine, Oncology, Pharmacology +12